Efficacy and safety of continuous glucose monitoring on glycaemic control in patients with chronic pancreatitis and insulin‐treated diabetes: A randomised, open‐label, crossover trial
Diabetes, Obesity and Metabolism · 2025
DOI: 10.1111/dom.16356 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Diabetes, Obesity and Metabolism, 2025. Verfasst von Line Davidsen und 7 weiteren Autor:innen. Beteiligte Einrichtung: Centre for Pancreatic Diseases and Mech-Sense, Department of Gastroenterology and Hepatology, Aalborg University Hospital, Aalborg, Denmark. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 1, Diabetes Mellitus, Type 2, Glycemic Control, Hypoglycemia. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: A.P. Møller and Chastine Mc-Kinney Møller Foundation, Dexcom, Inc, Steno Diabetes Centre North Denmark.
Themen: Diabetes mellitus
Abstract (Originalsprache)
Aims Continuous glucose monitoring (CGM) improves glycaemic control and reduces hypoglycaemia in type 1 and 2 diabetes, but its role in managing diabetes in chronic pancreatitis is unknown. We aimed to investigate the effect of CGM compared to self‐monitoring of blood glucose (SMBG) on hypoglycaemia and glycaemic control in patients with chronic pancreatitis and insulin‐treated diabetes. Materials and Methods In a randomised, open‐label, crossover trial, 30 participants with chronic pancreatitis and insulin‐treated diabetes were randomised to 50 days of CGM or SMBG, separated by a 20‐day washout period. The primary endpoint was time in level 2 hypoglycaemia (10.0 mmol/L; mean difference −6.55%, 95% CI −12.59% to −0.51%; p = 0.04), and reduced time below range (
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Centre for Pancreatic Diseases and Mech-Sense, Department of Gastroenterology and Hepatology, Aalborg University Hospital, Aalborg, Denmark.
- Department of Clinical Medicine, Aalborg University, Aalborg, Denmark.
- Department of Health Science and Technology, Aalborg University, Aalborg, Denmark.
- Department of Cardiology, North Denmark Regional Hospital, Hjørring, Denmark.
- Steno Diabetes Centre North Denmark, Aalborg University Hospital, Aalborg, Denmark.
- Center for Clinical Metabolic Research, Gentofte Hospital, University of Copenhagen, Hellerup, Denmark.
ORCID-Profile: Line Davidsen, Simon Lebech Cichosz, Morten Hasselstrøm Jensen
Förderung
- A.P. Møller and Chastine Mc-Kinney Møller Foundation
- Dexcom, Inc
- Steno Diabetes Centre North Denmark
- Heinrich Kopp's Grant
- Region North Denmark Health Science Research Foundation
- Dexcom
Zitieren
APA
Davidsen, L., Cichosz, S. L., Stæhr, P. B., Vestergaard, P., Drewes, A. M., Knop, F. K., Jensen, M. H., & Olesen, S. S. (2025). Efficacy and safety of continuous glucose monitoring on glycaemic control in patients with chronic pancreatitis and insulin‐treated diabetes: A randomised, open‐label, crossover trial. Diabetes, Obesity and Metabolism. https://doi.org/10.1111/dom.16356
Vancouver
Davidsen L, Cichosz SL, Stæhr PB, Vestergaard P, Drewes AM, Knop FK, et al. Efficacy and safety of continuous glucose monitoring on glycaemic control in patients with chronic pancreatitis and insulin‐treated diabetes: A randomised, open‐label, crossover trial. Diabetes, Obesity and Metabolism. 2025. doi:10.1111/dom.16356
BibTeX
@article{Davidsen2025,
author = {Davidsen, Line and Cichosz, Simon Lebech and Stæhr, Peter Bisgaard and Vestergaard, Peter and Drewes, Asbjørn M and Knop, Filip Krag and Jensen, Morten Hasselstrøm and Olesen, Søren Schou},
title = {Efficacy and safety of continuous glucose monitoring on glycaemic control in patients with chronic pancreatitis and insulin‐treated diabetes: A randomised, open‐label, crossover trial},
journal = {Diabetes, Obesity and Metabolism},
year = {2025},
doi = {10.1111/dom.16356}
}
EUVIMED